Table 1.
Clinical characteristics of patients who underwent genome biopsy with TBB
| Total patients (n = 572) | (%) | TBB patients (n = 236) | (%) | Re-biopsy in TBB patients (n = 24) | (%) | ||
|---|---|---|---|---|---|---|---|
| Age-median, [range] | Median | 68 [25–93] | 68 [25–93] | 67 [25–79] | |||
| Sex-no. (%) | Male | 365 | (63.8) | 143 | (60.6) | 10 | (41.6) |
| Female | 207 | (36.2) | 93 | (39.4) | 14 | (58.4) | |
| Histology-no. (%) | Ad including | 396 | (69.2) | 160 | (67.8) | 14 | (58.4) |
| Ad + SCLC | 2 | 0 | 0 | ||||
| Ad + Sq | 2 | 0 | 0 | ||||
| Sq | 99 | (17.3) | 50 | (21.2) | 5 | (20.8) | |
| NSCLC | 77 | (13.5) | 26 | (11.0) | 5 | (20.8) | |
| Stage-n. (%) | IVA, B | 416 | (72.7) | 171 | (72.5) | 21 | (87.5) |
| IIIA,B,C | 140 | (24.5) | 55 | (23.3) | 3 | (12.5) | |
| IIA, B | 16 | (2.8) | 10 | (4.2) | 0 | ||
| Tumor location.1 | Central | 69 | (29.2) | 14 | (58.4) | ||
| Peripheral | 167 | (70.8) | 10 | (41.6) | |||
| Tumor location.2 | Right | ||||||
| Upper and Middle | 82 | (34.7) | 10 | (41.6) | |||
| Lower | 42 | (17.8) | 6 | (25.0) | |||
| Left | |||||||
| Upper | 67 | (28.4) | 4 | (16.7) | |||
| Lower | 45 | (19.1) | 4 | (16.7) | |||
| Maximum diameter of tumor.(mm) | Median [range] | 39.3 [14.7–102.3] | 49.5 [15.6–82.0] | ||||
| ROSE | Positive | 21 | (87.5) | ||||
TBB transbronchial biopsy, Ad adenocarcinoma, SCLC small cell lung carcinoma, Sq squamous cell carcinoma, ROSE rapid-onsite evaluation